article
Issue #6 2013 – Digital edition
In Issue #6 2013: PAT in-depth focus, Lab Automation, Proteomics, Next Gen Sequencing, Screening in-depth focus, Microbiology...
List view / Grid view
Packaging & Labelling
article
Issue #5 2013 – Digital edition
Read the free digital version of Issue #5 2013 of European Pharmaceutical Review magazine...
article
Innovation showcase at CPhI Awards 2013
25 October 2013 | By Dr Kevin Robinson
It doesn’t seem to matter what the industry is or, indeed, what the event is these days, the same question pops up at regular intervals: where’s the innovation? I’m happy to report that innovation is very much alive and well in the pharmaceutical industry and was on show to the…
article
Issue #4 2013 – Digital edition
Read the free digital version of the August / September edition of European Pharmaceutical Review magazine...
article
RMMs & Environmental Monitoring In-Depth Focus 2013
In this RMMs & Environmental Monitoring In-Depth Focus: The rapid microbiological methods revolution; Controlling contamination in the pharmaceutical industry; Rapid Micro Methods Roundtable...
article
Issue #3 2013 – Digital version
Read the free digital version of the June / July edition of European Pharmaceutical Review magazine...
whitepaper
Whitepaper: Material identification using handheld spectroscopy
Understand the pros and cons of using correlation versus multivariate algorithms for material identification via handheld spectroscopy...
article
New guidelines for breakmarks on tablets
13 June 2013 | By Tony Moffat, UCL School of Pharmacy and Joint Pharmaceutical Analysis Group
The US Food and Drugs Administration (FDA) produced their guidance for industry on tablet scoring in March 2013 to ensure that tablet scoring (breakmarks or breaklines) on generic tablets would enable them to be split in the same effective way as their reference listed products (RLD).
article
Pharmaceutical Manufacturing & Packaging In-Depth Focus 2013
In this Pharmaceutical Manufacturing & Packaging In-Depth Focus: The chemical safety assessment process for extractables and leachables associated with packaged pharmaceutical products; INTERPHEX 2013: Show preview...
article
Hot topics in rapid methods: revisions to validation guidance and real-time environmental monitoring
18 December 2012 | By Michael J. Miller, President, Microbiology Consultants, LLC
This is the sixth and final paper in our continuing series on Rapid Microbiological Methods (RMM) that have appeared in European Pharmaceutical Review during 2012. As many of you already know, I am keen on staying on top of recent developments in the world of rapid methods, and have used…
webinar
Accelerating and Automated Rapid Microbial Testing
17 October 2012 | By Rapid Micro Biosystems
Experts in this webinar demonstrate how rapid technologies, like the Growth Direct™ System can have an impact on microbial quality control and ultimately manufacturing...
whitepaper
Whitepaper: New Support for ISO 14644-1
Changes in ISO 14644-1 to improve confidence in quality for critical life-science applications. Tony Harrison, UK Subject Matter Expert to ISO TC209 Working Group.
article
Implementation of high-throughput quality control processs within compound management
31 August 2011 | By Jerome Giovannoni and J.M. Peltier, Novartis
The constant growth of compound collections, combined with screening efforts on more challenging targets, is creating an increasing demand for quality control in order to ensure the integrity of the compound solutions being tested. This is true throughout the early drug discovery pipeline, from hit identification to lead nomination. Novartis…
news
Boehringer Ingelheim extends “one stop shop” service
20 June 2011 | By Boehringer Ingelheim
To round off its full-service capabilities for clients, Boehringer Ingelheim is expanding its capacities and capabilities in fill & finish for biopharmaceuticals at their state-of-the-art facility in Biberach, Germany, with a new filling line.
news
Why streamlining pharma supply chain is essential
17 May 2011 | By GDS International
For most pharmaceuticals executives, the prospect of the patent cliff is looming large in their thoughts...
